The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Abstract
OBJECTIVES : To examine the rate and predictors of nursing home placement in patients with Parkinson's disease. DESIGN : Four‐year prospective study. SETTING : A population‐based study in western Norway PARTICIPANTS : 178 community‐dwelling subjects with Parkinson's disease. MEASUREMENTS : Main outcome measure was the time from baseline to nursing home admission. Baseline evaluation of motor symptoms (Unified Parkinson's Disease Rating Scale, UPDRS), cognition (clinical dementia interview, Gottfries, Bråne & Steen dementia scale, and Mini‐Mental State Examination), depression (clinical interview and the Montgomery & Åsberg Depression Rating Scale), and psychotic symptoms (UPDRS Thought Disorder item) were performed. RESULTS : Forty‐seven patients (26.4%) were admitted to a nursing home during the 4‐year study period. Institutionalized patients were older, had more advanced Parkinson's disease with more severe motor symptoms and impairment of activities of daily living, were cognitively more impaired, were more often living alone, and had more hallucinations than those who continued to live at home. Duration of disease, levodopa dose, and gender distribution did not differ between the two groups. A Cox proportional hazards linear regression analysis showed that old age, functional impairment, dementia, and hallucinations were independent predictors of nursing home admission. CONCLUSIONS : Both motor and neuropsychiatric symptoms contributed to institutionalization, but the presence of hallucinations was the strongest predictor. This finding indicates it is possible that effective treatment of hallucinations may reduce the need for institutionalization in patients with Parkinson's disease. J Am Geriatr Soc 48:938–942, 2000 .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parkinson disease (PD) is progressive, with dementia and medication-refractory motor problems common reasons for late-stage nursing-home placement.”
From Does vigorous exercise have a neuroprotective effect in Parkinson disease? (2011) · cites this paper as [1]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
The Parkinson Study Group (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 618
Mental symptoms in Parkinson's disease are important contributors to caregiver distress
Aarsland, D., Larsen, J. P., Karlsen, K., Lim, N. G., & Tandberg, E. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199910)14:10 · Cited by 484
Self-citationRisk factors for nursing home placement in advanced Parkinson's disease
Goetz, C. G., & Stebbins, G. T. (1993) · Neurology · doi:10.1212/wnl.43.11.2227 · Cited by 460
A prospective study of long-term care institutionalization among the aged.
Branch, L. G., & Jette, A. M. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.12.1373 · Cited by 440
The Occurrence of Depression in Parkinson's Disease
Tandberg, E. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020087019 · Cited by 413
Self-citationPredictors of Institutionalization Among Caregivers of Patients With Alzheimer's Disease
Colerick, E. J., & George, L. K. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04239.x · Cited by 393
Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 347
Self-citation
Research works printed but not linked: 2
- Fahn S, 1987, Recent Development in Parkinson's Disease, 153
- 1987, Diagnostic and Statistical Manual of Mental Disorders
Cited by
Sorted by citations
Items 401–500 of 807
Drug-Induced Movement Disorders: Emergencies and Management
Robottom, B., Shulman, L. M., & Weiner, W. J. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.09.007 · Cited by 17
Pirogovsky‐Turk, E., Filoteo, J. V., Litvan, I., & Harrington, D. L. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150652 · Cited by 17
Hand, A., Gray, W. K., Oates, L. L., Woolford, M., Todd, A., Bale, E., Jones, C. L., Wood, B. H., & Walker, R. W. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.09.001 · Cited by 17
Citrome, L., Norton, J. C., Chi‐Burris, K., & Demos, G. (2017) · CNS Spectrums · doi:10.1017/s1092852917000736 · Cited by 18
Neuropsychiatric Symptoms and Caregiver Burden in Parkinson's Disease
Juneja, A., Anand, K. S., Chandra, M., Deshpande, S. N., Dhamija, R. K., Kathuria, P., & Mahajan, R. (2020) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_91_20 · Cited by 17
Yoo, H. S., Lee, S., Chung, S. J., Ye, B. S., Sohn, Y. H., Yun, M., & Lee, P. H. (2020) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000003281 · Cited by 17
Management of the behavioral aspects of Parkinson’s disease
Borek, L. L., Chou, K. L., & Friedman, J. H. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.6.711 · Cited by 18
Bernard, K., Mota, J. A., Wene, P. V., Corenblum, M. J., Saez, J. L., Bartlett, M. J., Heien, M. L., Doyle, K. P., Polt, R. L., Hay, M., et al. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114926 · Cited by 15
Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review)
Khalil, I., Sayad, R., Kedwany, A. M., Sayed, H. H., Caprara, A. L. F., & Rissardo, J. P. (2024) · Medicine International · doi:10.3892/mi.2024.194 · Cited by 19
Everyday reasoning abilities in persons with Parkinson's disease
Young, T. L., Granic, A., Chen, T., Haley, C. B., & Edwards, J. D. (2010) · Movement Disorders · doi:10.1002/mds.23379 · Cited by 16
Neuropsychiatric symptoms in Parkinson's disease: aetiology, diagnosis and treatment
Jones, S., Torsney, K., Scourfield, L., Berryman, K., & Henderson, E. (2020) · BJ Psych Advances · doi:10.1192/bja.2019.79 · Cited by 14
Isaacson, S., Coate, B., Norton, J., & Stankovic, S. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202047 · Cited by 17
The epidemiology of cognitive function in Parkinson's disease
Bock, M., & Tanner, C. M. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.004 · Cited by 18
Swick, T. J., Friedman, J. H., Chaudhuri, К. R., Surmann, E., Boroojerdi, B., Moran, K. A., Ghys, L., & Trenkwalder, C. (2014) · European Neurology · doi:10.1159/000355019 · Cited by 16
Jose, A., Bhargavan, A., Appireddy, R., P, S. B., Rajan, R., & Iype, T. (2021) · Neurology India · doi:10.4103/0028-3886.333437 · Cited by 16
Use of antiparkinson medications among elderly Medicare beneficiaries with Parkinson's disease
Wei, Y. J., Stuart, B., & Zuckerman, I. H. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2010.07.002 · Cited by 16
Counsell, C. E., Giuntoli, C., Khan, Q. I., Maple‐Grødem, J., & Macleod, A. D. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11058-2 · Cited by 15
Motor Memory Consolidation Deficits in Parkinson’s Disease: A Systematic Review with Meta-Analysis
Cristini, J., Parwanta, Z., Heras, B. D. L., Medina‐Rincón, A., Paquette, C., Doyon, J., Dagher, A., Steib, S., & Roig, M. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-230038 · Cited by 17
Advanced brain aging in Parkinson’s disease with cognitive impairment
Chen, C., Cheng, S.-Y., Montaser‐Kouhsari, L., Wu, W.-C., Hsu, Y., Tai, C., Tseng, W. I., Kuo, M., & Wu, R. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00673-7 · Cited by 15
Gerakios, F., Yarnall, A. J., Bate, G., Wright, L., Davis, D. H. J., Stephan, B. C. M., Robinson, L. A., Brayne, C., Stebbins, G. T., Taylor, J., et al. (2024) · Age and Ageing · doi:10.1093/ageing/afae046 · Cited by 15
Aitken, D., Naismith, S. L., Terpening, Z., & Lewis, S. J. G. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.11.031 · Cited by 15
Functional Status of Elderly Nursing Home Residents With Parkinson’s Disease
Chekani, F., Bali, V., & Aparasu, R. R. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160822 · Cited by 15
Chendo, I., Silva, C., Duarte, G. S., Prada, L., Voon, V., & Ferreira, J. J. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212930 · Cited by 15
Rajagopalan, K., Rashid, N., Kumar, S., & Doshi, D. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2152600 · Cited by 15
Dementia in Parkinson's Disease
Burn, D. J. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00012-x · Cited by 17
Institutionalization of Older People: Prediction and Prevention
Brown, S. H. M., & Abdelhafiz, A. H. (2011) · Aging Health · doi:10.2217/ahe.10.88 · Cited by 15
Hand, A., Oates, L. L., Gray, W. K., & Walker, R. W. (2018) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988718788680 · Cited by 15
Non-Motor Symptoms in Parkinson’s Disease: An Underdiagnosed Problem
Muzerengi, S., Lewis, H., Edwards, M. J., Kipps, E., Bahl, A., Martínez‐Martín, P., & Chaudhuri, К. R. (2006) · Aging Health · doi:10.2217/1745509x.2.6.967 · Cited by 15
Kurpershoek, E., Hillen, M. A., Medendorp, N. M., de Bie, R. M. A., de Visser, M., & Dijk, J. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.683094 · Cited by 14
Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis
Abler, V., Brain, C., Ballard, C. G., Berrio, A., Coate, B., & Espay, A. J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.919778 · Cited by 14
High frequency of psychosis in late-stage Parkinsońs disease
Chendo, I., Fabbri, M., Godinho, C., Simões, R. M., Sousa, C. S. E., Coelho, M. M., Voon, V., & Ferreira, J. J. (2021) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2021.100119 · Cited by 14
Swarztrauber, K., Graf, E., & Cheng, E. M. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-26 · Cited by 14
Sleep disturbance and neurological disease
Smith, I. E., & Anderson, K. N. (2011) · Clinical Medicine · doi:10.7861/clinmedicine.11-3-271 · Cited by 14
Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
Kehagia, A. A. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00110 · Cited by 14
Evidence for the use of pimavanserin in the treatment of Parkinson’s disease psychosis
Sarva, H., & Henchcliffe, C. (2016) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285616664300 · Cited by 14
Psychotic symptoms in Parkinson?s disease: pathophysiology and management
Bosboom, J. L. W., & Wolters, E. C. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.3.209 · Cited by 14
Garuda, B. R., Pappala, K., Seepana, G., Thalabaktula, S., & Uppaturi, A. (2019) · Annals of Movement Disorders · doi:10.4103/aomd.aomd_9_19 · Cited by 13
Horne, K., MacAskill, M. R., Myall, D. J., Livingston, L., Grenfell, S., Pascoe, M. J., Young, B., Shoorangiz, R., Melzer, T. R., Pitcher, T. L., et al. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13151 · Cited by 13
Salgado, A. M. R., Acosta, I., Kim, D. J., Zitser, J., Sosa, A. L., Acosta, D. M., Jimenez‐Velasquez, I. Z., Guerra, M., Salas, A., Valvuerdi, A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13384 · Cited by 14
Investigating the night-to-night variability of REM without atonia in Parkinson's disease
Bolitho, S., Naismith, S. L., Terpening, Z., Grunstein, R. R., Melehan, K. L., Yee, B. J., Coeytaux, A., & Lewis, S. J. G. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.08.007 · Cited by 13
Thieken, F., & van Munster, M. (2021) · Brain Sciences · doi:10.3390/brainsci11121629 · Cited by 13
Depressive symptoms in Parkinson's disease
Piccinni, A., Marazziti, D., Veltri, A., Ceravolo, R., Ramacciotti, C., Carlini, M., Debbio, A. D., Schiavi, E., Bonuccelli, U., & Dell’Osso, L. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2011.11.002 · Cited by 13
Serino, S., Pedroli, E., Cipresso, P., Pallavicini, F., Albani, G., Mauro, A., & Riva, G. (2014) · Intelligent systems reference library · doi:10.1007/978-3-642-54816-1_14 · Cited by 14
Haasum, Y., Fastbom, J., & Johnell, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161246 · Cited by 13
Current Understanding of Psychosis in Parkinson’s Disease
Ojo, O. O., & Fernandez, H. H. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0730-1 · Cited by 13
Onset and Remission of Psychosis in Parkinson's Disease: Pharmacologic and Motoric Markers
Hinkle, J. T., Perepezko, K. M., Bakker, C. C., Broen, M. P. G., Chin, K., Dawson, T. M., Johnson, V., Mari, Z. K., Marvel, C. L., Mills, K. A., et al. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12550 · Cited by 13
Conner, M. R., Jang, D., Anderson, B. J., & Kritzer, M. F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00942 · Cited by 14
Management of Dysphagia and Drooling in Patients With Parkinson’s Disease
Kalf, J. G. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.77 · Cited by 13
Community and Long-Term Care Management of Parkinson???s Disease in the Elderly
Chen, J. J., & Fernandez, H. H. (2007) · Drugs & Aging · doi:10.2165/00002512-200724080-00004 · Cited by 13
Steendam-Oldekamp, E., Weerkamp, N. J., Vonk, J. M., Bloem, B. R., & van Laar, T. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1128891 · Cited by 12
Guttuso, T. J., Shepherd, R., Frick, L. R., Feltri, M. L., Frerichs, V. A., Ramanathan, M. K., Zivadinov, R., & Bergsland, N. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.05.001 · Cited by 12
Albujuq, N. R., Meana, J. J., Dı́ez-Alarcia, R., Arrate, I. M., Naqvi, A., Althumayri, K., & Alsehli, M. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00662 · Cited by 12
Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice
Dashtipour, K., Gupta, F., Hauser, R. A., Karunapuzha, C. A., & Morgan, J. C. (2021) · Parkinson s Disease · doi:10.1155/2021/2603641 · Cited by 12
Fiorilli, G., Quinzi, F., Buonsenso, A., Casazza, G., Manni, L., Parisi, A., Costanzo, A. D., Calcagno, G., Soligo, M., & di Cagno, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18105499 · Cited by 17
Brown, J. D., Cicali, B., Henriksen, C. H., Malaty, I. A., Okun, M. S., & Armstrong, M. J. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.6.785 · Cited by 12
Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanisms
Zhang, S., & Ma, Y. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i9.1127 · Cited by 12
What matters to people with Parkinson’s disease living in Australia?
Lee, J. M., Shine, J. M., & Lewis, S. J. G. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.06.097 · Cited by 12
Parkinson’s disease permanent care unit: managing the chronic-palliative interface
Lökk, J. (2011) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s17713 · Cited by 12
Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA
Rodríguez‐Violante, M., Cervantes‐Arriaga, A., Velázquez‐Osuna, S., Llorens‐Arenas, R., Calderón‐Fajardo, H., Piña‐Fuentes, D., & Martínez‐Martín, P. (2014) · Parkinson s Disease · doi:10.1155/2014/260485 · Cited by 12
Sieb, J. P., Themann, P., Warnecke, T., Lauterbach, T., Berkels, R., Grieger, F., & Lorenzl, S. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1030376 · Cited by 12
Mortality of advanced Parkinson's disease patients treated with deep brain stimulation surgery
Ryu, H., Kim, M. S., You, S., Kim, M., Kim, Y. J., Kim, J., Kim, K., & Chung, S. J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.08.041 · Cited by 12
Bian, G., Liu, J., Guo, Y., Yang, Y., Li, L., Qiao, H., Li, W., Xu, T., & Zhang, Q. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108012 · Cited by 13
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s Disease
Orgeta, V., McDonald, K. R., Poliakoff, E., Hindle, J. V., Clare, L., & Leroi, I. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011961 · Cited by 12
Longitudinal testing of visual perception in dementia with Lewy bodies and Alzheimer's disease
Wood, J. S., Watson, R., Firbank, M., Mosimann, U. P., Barber, R., Blamire, A. M., & O'Brien, J. T. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3860 · Cited by 12
Gordon, P. C., Kauark, R. B. G., Costa, C. D. M., de Oliveira, M. O., Godinho, F. L. F., & Rocha, M. S. G. (2015) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15050119 · Cited by 12
Supporting self-management in early dementia: a contribution towards ‘living well’?
Cheffey, J., Hill, L., Roberts, G. A., & Marlow, R. (2013) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.112.011023 · Cited by 12
Modernizing the Staging of Parkinson Disease Using Digital Health Technology
Templeton, J. M., Poellabauer, C., Schneider, S. L., Rahimi, M., Braimoh, T., Tadamarry, F., Margolesky, J. H., Burke, S. L., & Masry, Z. A. (2025) · Journal of Medical Internet Research · doi:10.2196/63105 · Cited by 13
Health Care Resource Utilization Associated With Parkinson Disease Among Medicare Beneficiaries
Gandhi, A. B., Onukwugha, E., Albarmawi, H., Johnson, A. M., Myers, D. E., Gray, D. L., Alvir, J. M., Hynicka, L. M., & Shulman, L. M. (2021) · Neurology · doi:10.1212/wnl.0000000000012290 · Cited by 11
Association of caregiver strain with the trajectory of quality of life in Parkinson's disease
Perepezko, K. M., Gallo, J. J., Pontone, G. M., Hinkle, J. T., & Mills, K. A. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105292 · Cited by 11
On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis
Pagán, F., Schulz, P. E., Torres-Yaghi, Y. A., & Pontone, G. M. (2024) · CNS Drugs · doi:10.1007/s40263-024-01084-1 · Cited by 11
Demenz und Depression determinieren Pflegebedürftigkeit bei M. Parkinson
Riedel, O., Dodel, R. C., Deuschl, G., Förstl, H., Henn, F. A., Heuser, I., Oertel, W. H., Reichmann, H., Riederer, P. F., Trenkwalder, C., et al. (2011) · Der Nervenarzt · doi:10.1007/s00115-010-3186-2 · Cited by 11
Domain‐specific cognitive impairment in non‐demented Parkinson's disease psychosis
Hinkle, J. T., Perepezko, K. M., Bakker, C. C., Dawson, T. M., Johnson, V., Mari, Z. K., Marvel, C. L., Mills, K. A., Pantelyat, A. Y., Pletniková, O., et al. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4736 · Cited by 11
When time is of the essence: Managing care in emergency situations in Parkinson's disease
Prasad, S., & Pal, P. K. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.09.016 · Cited by 11
Diplopia in Parkinson's disease: Indication of a cortical phenotype with cognitive dysfunction?
Naumann, W., Gogarten, J. H., Schönfeld, S., Klostermann, F., Marzinzik, F., & Schindlbeck, K. A. (2021) · Acta Neurologica Scandinavica · doi:10.1111/ane.13479 · Cited by 11
Accuracy of Two Cognitive Screening Tools to Detect Mild Cognitive Impairment in Parkinson's Disease
Koevoets, E. W., Schmand, B. A., & Geurtsen, G. J. (2018) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12597 · Cited by 11
Managing Psychosis in Parkinson’s Disease Without Drugs
Wand, A. P. F., & Peisah, C. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.27 · Cited by 11
Activity Monitoring in Parkinson Disease: A Qualitative Study of Implementation Determinants
King, B. F., MacDonald, J. R., Stoff, L., Nettnin, E. A., Jayaraman, A., Goldman, J. G., & Rafferty, M. R. (2023) · Neurology Report · doi:10.1097/npt.0000000000000451 · Cited by 10
Therapeutic singing-induced swallowing exercise for dysphagia in advanced-stage Parkinson’s disease
Yeo, M. S., Hwang, J., Lee, H. K., Kim, S. J., & Cho, S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1323703 · Cited by 10
Gibson, L. L., Mueller, C., Stewart, R. J., & Aarsland, D. (2024) · Psychological Medicine · doi:10.1017/s0033291724001922 · Cited by 10
Self-citationJeong, S. H., Yoo, H. S., Chung, S. J., Jung, J. H., Lee, Y. H., Baik, K., Sohn, Y. H., & Lee, P. H. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212660 · Cited by 10
Lopez, F., Kenney, L. E., Ratajska, A. M., Jacobson, C., & Bowers, D. (2021) · Clinical Neuropsychologist · doi:10.1080/13854046.2021.1999505 · Cited by 10
Sulzer, P., Bäumer, A., Hoang, H. G., Becker, S., Loenneker, H. D., Graessel, E., & Liepelt‐Scarfone, I. (2019) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617719001322 · Cited by 10
Improving Detection of Psychiatric Disturbances in Parkinson's Disease: The Role of Informants
Hirsch, E. S., Adler, G., Amspoker, A. B., Williams, J. R., & Marsh, L. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120170 · Cited by 10
Diagnosing and Treating Depression in Patients With Parkinson's Disease
Weintraub, D. A. (2004) · Psychiatric Annals · doi:10.3928/0048-5713-20040401-10 · Cited by 10
Do Co-Morbidities and Cognition Impact Functional Change and Discharge Needs in Parkinson Disease?
Marciniak, C. M., Choo, C. M., Toledo, S. D., Semik, P. E., & Aagesen, A. L. (2011) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e31820b15a2 · Cited by 10
Parkinson's disease patients in institutionalized care
Keränen, P., Martikainen, K. K., Keränen, T., & Marttila, R. J. (2013) · European Geriatric Medicine · doi:10.1016/j.eurger.2013.06.011 · Cited by 10
Popescu, A., & Lippa, C. F. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.04.011 · Cited by 10
Management of Neuropsychiatric Symptoms in Long-Term Care Residents with Parkinson’s Disease
Herrmann, N., Marras, C., Fischer, H. D., Wang, X., Anderson, G., & Rochon, P. A. (2012) · Drugs & Aging · doi:10.1007/s40266-012-0038-8 · Cited by 9
Dahbour, S. S., Murr, M. J. A., Oweis, L., Al‐Antary, N., Mohsen, M., & Fegi, S. A. (2022) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-022-00559-6 · Cited by 9
Schröter, N., Bormann, T., Rijntjes, M., Blazhenets, G., Berti, R., Sajonz, B., Urbach, H., Weiller, C., Meyer, P. T., Rau, A., et al. (2023) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13792 · Cited by 9
Specketer, K., Zabetian, C. P., Edwards, K. L., Tian, L., Quinn, J. F., Peterson‐Hiller, A. L., Chung, K. A., Hu, S., Montine, T. J., & Cholerton, B. (2019) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2019.1623180 · Cited by 9
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00004-4 · Cited by 9
Cognitive Impairment in Parkinson’s Disease: What We Know so Far
Painous, C., & Martı́, M. J. (2020) · Research and Reviews in Parkinsonism · doi:10.2147/jprls.s263041 · Cited by 9
MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice
Santos‐García, D., Saúco, M. Á., Calopa, M., Carrillo, F., Sevilla, F. E., Freire, E., Ramos, R. G., Kulisevsky, J., Gómez‐Esteban, J. C., Legarda, I., et al. (2021) · Diagnostics · doi:10.3390/diagnostics12010055 · Cited by 9
Chen, J., Chen, B., Zhao, D., Feng, X., Wang, Q., Li, Y., Chen, J., Bai, C., Guo, X., He, X., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14651 · Cited by 9
Use of antipsychotic medications in patients with Parkinson's disease at Auckland City Hospital
Bloomfield, K., MacDonald, L., Finucane, G., Snow, B. J., & Roxburgh, R. H. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02499.x · Cited by 9
Álvarez-Avellón, T., Arias-Carrión, Ã., & Menéndez, M. (2015) · Neurology and Neuroscience · doi:10.3823/352 · Cited by 9
Combating psychosis in Parkinson’s disease patients: the use of antipsychotic drugs
Chou, K. L., & Fernandez, H. H. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.4.339 · Cited by 9
Latent Cognitive Phenotypes in De Novo Parkinson’s Disease: A Person-Centered Approach
LaBelle, D. R., Walsh, R. R., & Banks, S. J. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000406 · Cited by 13
Klaptocz, J., Gray, W. K., Marwood, S., Agarwal, M., Ziegler, J., Webb, Z., Prabhakar, M., Hand, A., Oates, L. L., McDonald, C., et al. (2018) · Journal of Aging and Health · doi:10.1177/0898264318786125 · Cited by 9
Metadata
- Authors
- Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K.
- Affiliations
- Stavanger University Hospital (NO)
- Oslo University Hospital (NO)
- Corresponding author
- Aarsland, Dag
- ORCID
- Aarsland, Dag
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 48
- Issue
- 8
- Pages
- 938-942
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2083220625
- Cited by
- 811
- References
- 21
- Citations by year
- 2026: 15 · 2025: 30 · 2024: 30 · 2023: 33 · 2022: 33 · 2021: 42 · 2020: 64 · 2019: 36 · 2018: 35 · 2017: 36 · 2016: 37 · 2015: 32 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Geriatrics Society (publishedVersion)
- PubMed (publishedVersion)
- Journal of the American Geriatrics Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, nursing home admission, institutionalization, predictors of institutionalization, hallucinations, dementia, functional disability, activities of daily living, motor symptoms, neuropsychiatric symptoms, depression, community-dwelling patients
- MeSH terms
- Activities of Daily Living, Adult, Aged, Aged, 80 and over, Dementia, Female, Hallucinations, Humans, Male, Middle Aged, Norway, Nursing Homes, Parkinson Disease, Patient Admission, Predictive Value of Tests, Prospective Studies, Psychiatric Status Rating Scales, Risk Factors, Severity of Illness Index, Geriatric Assessment, Linear Models, Proportional Hazards Models, Age Distribution, Community Health Planning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review